Topic
4 articles
The Ebola outbreak in the Democratic Republic of Congo has surpassed 4,000 cases, becoming the world's second-largest and fastest-spreading outbreak on record. WHO experts recommend large-scale trials of the Ervebo vaccine to test its cross-protection against the Bundibugyo strain.
The U.S. Senate confirmed Erica Schwartz as CDC director on February 4 with a 51-44 vote, marking the first confirmation for the role since 2025. She takes over an agency reeling from staff departures, political pressure, and public health emergencies, including a severe measles outbreak.
At least three Ebola vaccines are being urgently researched and funded as a rare Bundibugyo strain outbreak spreads across East Africa, with hundreds infected and no approved vaccine for this strain. The outbreak began in eastern DRC's conflict-hit Ituri province and has spread to Uganda. While vaccines exist for the more common Zaire strain, none have been approved for Bundibugyo, prompting accelerated trials.
The WHO has declared the rare Bundibugyo Ebola strain outbreak in the DRC and Uganda a global health emergency. With a fatality rate of up to 50%, no specific vaccine or treatment is yet approved. Experts warn of diagnostic challenges and call for sustained global investment in vaccine development.
